Abstract
5/2021
vol. 13
Case report
Brachytherapy for oligometastatic prostate cancer to the penis
- Department of Radiation Therapy, Antoine Lacassagne Cancer Center and University of Nice-Sophia, University Cote d’Azur, Nice, France
- Department of Radiotherapy, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
- Department of Radiotherapy, Bergonié Institute, Bordeaux, France
- Department of Nuclear Medicine, Paoli Calmettes Institute, Marseille, France
- Department of Radiation Therapy, Paoli Calmettes Institute, Marseille, France
- Department of Urology, University of Nice Sophia-Antipolis, Hôpital Archet 2, Centre Hospitalier Universitaire de Nice, France
J Contemp Brachytherapy 2021; 13, 5: 593–597
Online publish date: 2021/10/06
The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis.
We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and 68Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance.
We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and 68Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance.
Keywords
prostate cancer, penile cancer, brachytherapy, oligometastasis
Integrated with
